FEV1/FVC and FEV1/FEV6 in 8776 patients with normal lung function or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 715s Year: 2005
Comparison of prebronchodilator FEV1/FEV6 of handheld spirometry with postbronchodilator FEV1/FVC of spirometry in Korea: a pilot study Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
FEV1/FEV6 versus FEV1/FVC in the spirometric detection of airway obstruction among Asians Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Repeatability study comparing plethysmographic and spirometric lung function parameters in COPD patients, asthmatics, and healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 221s Year: 2006
Longitudinal modeling of prebronchodilator FEV1 response to benralizumab for patients with severe asthma Source: International Congress 2017 – Asthma management Year: 2017
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Should we use FEV1/FVC <0.70 or FEV1/FVC <LLN to identify subjects with a clinical history indicating COPD – Results from the population-based BOLD study in Salzburg, Austria Source: Annual Congress 2011 - COPD diagnosis Year: 2011
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1 /FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
A systematic review of the accuracy of microspirometry for screening of adults for COPD Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011
Prospective analysis of lung function in COPD patients – home monitoring of FEV1 and PEF (PIKO®1) Source: Eur Respir J 2006; 28: Suppl. 50, 108s Year: 2006
FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010